These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32085923)

  • 41. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
    Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
    J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial.
    McHaffie DR; Chabot P; Dagnault A; Suh JH; Fortin MA; Chang E; Timmerman R; Souhami L; Grecula J; Nabid A; Schultz C; Werner-Wasik M; Gaspar LE; Brachman D; Mody T; Mehta MP
    J Neurooncol; 2011 Nov; 105(2):301-8. PubMed ID: 21523486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.
    Yomo S; Hayashi M
    J Neurooncol; 2013 Jul; 113(3):459-65. PubMed ID: 23661101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.
    Aoyama H; Tago M; Kato N; Toyoda T; Kenjyo M; Hirota S; Shioura H; Inomata T; Kunieda E; Hayakawa K; Nakagawa K; Kobashi G; Shirato H
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1388-95. PubMed ID: 17674975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
    Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.
    Yamamoto M; Serizawa T; Shuto T; Akabane A; Higuchi Y; Kawagishi J; Yamanaka K; Sato Y; Jokura H; Yomo S; Nagano O; Kenai H; Moriki A; Suzuki S; Kida Y; Iwai Y; Hayashi M; Onishi H; Gondo M; Sato M; Akimitsu T; Kubo K; Kikuchi Y; Shibasaki T; Goto T; Takanashi M; Mori Y; Takakura K; Saeki N; Kunieda E; Aoyama H; Momoshima S; Tsuchiya K
    Lancet Oncol; 2014 Apr; 15(4):387-95. PubMed ID: 24621620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases.
    Soon YY; Tham IW; Lim KH; Koh WY; Lu JJ
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD009454. PubMed ID: 24585087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
    Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
    Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy.
    Hsu F; Kouhestani P; Nguyen S; Cheung A; McKenzie M; Ma R; Toyota B; Nichol A
    Radiother Oncol; 2013 Jul; 108(1):128-31. PubMed ID: 23742960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.
    Westover KD; Mendel JT; Dan T; Kumar K; Gao A; Pulipparacharuv S; Iyengar P; Nedzi L; Hannan R; Anderson J; Choe KS; Jiang W; Abdulrahman R; Rahimi A; Folkert M; Laine A; Presley C; Cullum CM; Choy H; Ahn C; Timmerman R
    Neuro Oncol; 2020 Dec; 22(12):1831-1839. PubMed ID: 32347302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both.
    El Gantery MM; Abd El Baky HM; El Hossieny HA; Mahmoud M; Youssef O
    Radiat Oncol; 2014 May; 9():116. PubMed ID: 24884624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases.
    Schüttrumpf LH; Niyazi M; Nachbichler SB; Manapov F; Jansen N; Siefert A; Belka C
    Radiat Oncol; 2014 May; 9():105. PubMed ID: 24885624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
    Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
    J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective Evaluation of Response to Treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-Brain Metastasis Treated with Only SRS.
    Dutta D; Reddy SK; Kamath RK; Sreenija Y; Nair H; Sashidharan A; Remesan Nair RA; Pushpuja KU; Kannan R; Edappattu A; Haridas NK; Jose WM; Keechilat P
    Neurol India; 2023; 71(1):62-71. PubMed ID: 36861576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
    Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.